During the past decade, Northwest Wisconsin Cancer Center conducted 78 clinical trials. In the 10-year time frame, 78 clinical trials started and 8 clinical trials were completed, i.e. on average, 10.3% percent of trials that started reached the finish line to date. In the past 5 years, 38 clinical trials started and 8 clinical trials were completed. i.e. 21.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Northwest Wisconsin Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 37 trials, followed by "Alliance for Clinical Trials in Oncology" with 15 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 10 trials sponsored, "SWOG Cancer Research Network" with 10 trials sponsored and "NRG Oncology" with 10 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northwest Wisconsin Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 43 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "NRG Oncology" with 5 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Brain Science Foundation" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Northwest Wisconsin Cancer Center" are "Stage IV Lung Cancer AJCC v8" (7 trials), "Stage IVA Lung Cancer AJCC v8" (5 trials), "Stage IVB Lung Cancer AJCC v8" (5 trials), "Recurrent Lung Non-Small Cell Carcinoma" (4 trials) and "Breast Carcinoma" (3 trials). Many other conditions were trialed in "Northwest Wisconsin Cancer Center" in a lesser frequency.

Most popular intervention types in "Northwest Wisconsin Cancer Center" are "Drug" (61 trials), "Other" (43 trials), "Biological" (39 trials), "Procedure" (30 trials) and "Radiation" (16 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (20 trials), "Computed Tomography" (18 trials), "Nivolumab" (18 trials), "Questionnaire Administration" (17 trials) and "Biospecimen Collection" (16 trials). Other intervention names were less common.

The vast majority of trials in "Northwest Wisconsin Cancer Center" are 73 trials for "All" genders, 4 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Northwest Wisconsin Cancer Center". undefined are not yet recruiting, 38 are recruiting, 31 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Northwest Wisconsin Cancer Center, 5 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Northwest Wisconsin Cancer Center, 2 "Phase 1" clinical trials were conducted, 43 "Phase 2" clinical trials and 34 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".